Bank of America
ICVX

Bank of America’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bank of America’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,272
Closed -$556K – 8367
2023
Q4 		$556K Buy
35,272
+1,967
+6% +$18.9K ﹤0.01% 5419
2023
Q3 		$258K Buy
33,305
+8,697
+35% +$72.1K ﹤0.01% 5745
2023
Q2 		$244K Sell
24,608
-15,566
-39% -$125K ﹤0.01% 5709
2023
Q1 		$233K Buy
40,174
+14,277
+55% +$123K ﹤0.01% 5838
2022
Q4 		$206K Buy
25,897
+14,801
+133% +$63.5K ﹤0.01% 5892
2022
Q3 		$35K Buy
11,096
+4,837
+77% +$30.3K ﹤0.01% 6822
2022
Q2 		$36K Sell
6,259
-55,237
-90% -$431K ﹤0.01% 6978
2022
Q1 		$433K Buy
61,496
+57,902
+1,611% +$911K ﹤0.01% 5928
2021
Q4 		$82K Buy
3,594
+2,218
+161% +$57.3K ﹤0.01% 6982
2021
Q3 		$41K Buy
+1,376
New +$46.6K ﹤0.01% 7141

Bank of America's ICVX Position: Q1 2024 in Review

Bank of America sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 35,272 shares — an estimated $556K sold.

Bank of America first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $556K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Bank of America reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 35,272 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $556K.
  • Bank of America first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Bank of America's Icosavax, Inc. Common Stock position peaked at $556K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.